Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Interest Expenses (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Interest Expenses readings, the most recent being $10776.0 for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 52.05% to $10776.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $134123.0, a 1031.99% increase, with the full-year FY2025 number at $136262.0, up 1138.75% from a year prior.
  • Interest Expenses reached $10776.0 in Q1 2026 per CBIH's latest filing, up from $3230.0 in the prior quarter.
  • The five-year high for Interest Expenses was $102749.0 in Q2 2025, with the low at -$47904.0 in Q2 2024.
  • A 5-year average of $19325.5 and a median of $10776.0 in 2026 define the central range for Interest Expenses.
  • Year-over-year, Interest Expenses plummeted 4072.14% in 2024 and then surged 642.54% in 2025.
  • Year by year, Interest Expenses stood at $36278.0 in 2022, then plummeted by 86.2% to $5005.0 in 2023, then skyrocketed by 73.85% to $8701.0 in 2024, then crashed by 62.88% to $3230.0 in 2025, then soared by 233.62% to $10776.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Interest Expenses are $10776.0 (Q1 2026), $3230.0 (Q4 2025), and $17368.0 (Q3 2025).